Cassava Sciences, Inc. (SAVA)
USD 2.41
(-5.49%)
USD 2.41
(-5.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -82.02 Million | -77.51 Million | -30.19 Million | -5.38 Million | -2.51 Million | -4.77 Million |
| Net Income | -97.21 Million | -76.24 Million | -32.38 Million | -6.33 Million | -4.63 Million | -6.55 Million |
| Depreciation & Amortization | 1.53 Million | 1.3 Million | 534 Thousand | 22 Thousand | 58 Thousand | 69 Thousand |
| Deferred income taxes | -6.89 Million | -8.11 Million | 3.38 Million | - | -1.25 Million | - |
| Stock-based compensation | 4.58 Million | 2.06 Million | 1.75 Million | 988 Thousand | 1.29 Million | 2.38 Million |
| Change in working capital | 9.07 Million | -4.63 Million | -104 Thousand | 288 Thousand | 763 Thousand | -670 Thousand |
| Other non-cash items | 6.89 Million | 8.11 Million | -3.38 Million | -346 Thousand | 1.25 Million | 2.65 Million |
| Investing Cash Flow | -414 Thousand | -2.71 Million | -22.21 Million | 360 Thousand | -18 Thousand | - |
| Investments in PPE | -414 Thousand | -2.71 Million | -22.21 Million | - | -18 Thousand | - |
| Acquisitions | - | - | - | 360 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 360.00 | - | - |
| Financing Cash Flow | 2.56 Million | 47.8 Million | 192.34 Million | 75.44 Million | 5.8 Million | 14.09 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -60 Thousand | - |
| Common Stock Issuance | 2.56 Million | 47.32 Million | 192.34 Million | 70.25 Million | -60 Thousand | 14.09 Million |
| Other Financing Activities | 2.56 Million | 475 Thousand | 192.34 Thousand | 5.19 Million | 5.92 Million | 14.09 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 6.89 Million | -3.44 Million | 6.21 Million | 458 Thousand | 159 Thousand | -130 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.18 Million | -1.18 Million | -6.31 Million | -170 Thousand | 604 Thousand | -540 Thousand |
| Cash at beginning of period | 201.01 Million | 233.43 Million | 93.5 Million | 23.08 Million | 19.8 Million | 10.47 Million |
| Cash at end of period | 121.13 Million | 201.01 Million | 233.43 Million | 93.5 Million | 23.08 Million | 19.8 Million |
| Capital Expenditure | -414 Thousand | -2.71 Million | -22.21 Million | - | -18 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -79.87 Million | -32.42 Million | 139.93 Million | 70.42 Million | 3.27 Million | 9.32 Million |
| Free Cash Flow | -82.43 Million | -80.22 Million | -52.41 Million | -5.38 Million | -2.53 Million | -4.77 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.15 Million | 25.04 Million | -20.91 Million | -97.21 Million | -25.65 Million | -26.37 Million |
| Depreciation & Amortization | 300 Thousand | 311 Thousand | 356 Thousand | 1.53 Million | 392 Thousand | 391 Thousand |
| Deferred income taxes | - | - | -3.99 Million | -6.89 Million | 405 Thousand | 479 Thousand |
| Stock-based compensation | 2.6 Million | 2.33 Million | 2.12 Million | 4.58 Million | 949 Thousand | 835 Thousand |
| Change in working capital | 37.84 Million | -3.77 Million | -3.88 Million | 9.07 Million | -2.22 Million | 5.22 Million |
| Other non-cash items | -104.88 Million | -39.11 Million | 3.99 Million | 6.89 Million | -405 Thousand | -479 Thousand |
| Investing Cash Flow | -29 Thousand | - | -41 Thousand | -414 Thousand | -22 Thousand | 6000.00 |
| Investments in PPE | -29 Thousand | - | -41 Thousand | -414 Thousand | -22 Thousand | 6000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 101.39 Million | 22.16 Million | 1.14 Million | 2.56 Million | 464 Thousand | 889 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 101.39 Million | 22.16 Million | 1.14 Million | 2.56 Million | 464 Thousand | 889 Thousand |
| Other Financing Activities | 101.39 Million | 22.16 Million | 2.56 Million | 2.56 Million | 464.00 | 889.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 42.94 Million | -970 Thousand | 1.08 Million | 6.89 Million | -846 Thousand | 2.09 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5.1 Million | -2.8 Million | -4.96 Million | 2.18 Million | -1.37 Million | 3.13 Million |
| Cash at beginning of period | 124.16 Million | 121.13 Million | 142.35 Million | 201.01 Million | 168.43 Million | 187.46 Million |
| Cash at end of period | 207.29 Million | 124.16 Million | 121.13 Million | 121.13 Million | 142.35 Million | 168.43 Million |
| Capital Expenditure | -29 Thousand | - | -41 Thousand | -414 Thousand | -22 Thousand | 6000.00 |
| Effect of forex changes on cash | - | - | -26.49 Million | - | 26.49 Million | - |
| Net cash flow / Change in cash | 83.12 Million | 3.03 Million | -21.21 Million | -79.87 Million | -26.08 Million | -19.02 Million |
| Free Cash Flow | -18.27 Million | -19.12 Million | -22.35 Million | -82.43 Million | -26.55 Million | -19.91 Million |
600368
6093
MDNA
603797
RAMANEWS
XLO